Make Your Voice Heard: Contact Your Representative on Behalf of Longevity Science

By Dylan V. Livingston In our journey to advance the longevity industry, grassroots efforts like ours hold immense potential to create change. To truly impact the future longevity science and human health, we need a committed community advocating constantly for the industry. To that end, we must ensure that our voices are heard by the […]

H-SPAN Podcast EP 7: Andrew Steele

This week on H-Span, we’re thrilled to be joined by Andrew Steele, a physicist turned biologist who made the switch after determining that aging was “the single most important scientific challenge of our time.” In this episode, we discuss how Andrew first got involved with the longevity movement, as well as his thoughts on the […]

Governor of Montana Approves Bill Expanding Patient Access to Experimental Treatments

Governor of Montana Approves Bill Expanding Patient Access to Experimental Treatments May 12, 2023 – The Alliance for Longevity Initiatives (A4LI) celebrates the recent signing of Montana Senate Bill No. 422 by Governor Greg Gianforte. PDF The Advanced Approval Pathway for Longevity MedicinesThe Advanced Approval Pathway for Longevity Medicines 

Make Medicine, Not War: Why Longevity Medicine Could Be the Key to Global Stability

Make Medicine, Not War: Why Longevity Medicine Could Be the Key to Global Stability By Dylan V. Livingston The ongoing demographic shift across the globe has far-reaching consequences that touch various aspects of society, specifically global politics. As nations face the challenges of aging populations, they must grapple with the need to maintain a stable […]

The Advanced Approval Pathway for Longevity Medicines (AAPLM)

The Advanced Approval Pathway for Longevity Medicines (AAPLM) seeks to accelerate the development of groundbreaking therapies targeting aging, improving health, reducing healthcare costs, and boosting economic productivity. AAPLM’s provisions include a faster drug approval track, priority review vouchers to incentivize innovation, and patent term extensions to encourage broad therapeutic applications. By aligning economic incentives with […]